Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/2/26 18:30 | 2/2/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Tabuteau Herriot | NY | DOT | CEO | 3 | S.dm | -41,545 | 165.00 | 0 | -252 | 7,352 | D | |||||||||||||||
1/23/26 19:00 | 1/22/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Pizzie Nick | NY | O | CFO | 1 | S.d | -2,255 | 187.92 | 0 | -12 | 43 | D | |||||||||||||||
1/23/26 19:00 | 1/21/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Maizel Ari | NY | O | Chief Co | 1 | S.d | -1,383 | 184.44 | 0 | -8 | -100 | 0 | D | ||||||||||||||
1/2/26 19:02 | 12/31/25 | AXSM | Health | Drug | Pharmaceutical Preparations | Saad Mark E | NY | D | 1 | S.d | -6,207 | 165.18 | 0 | -38 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |